Berberine is a plant alkaloid with effects comparable to metformin on insulin sensitivity. Strong evidence for diabetes, PCOS, and lipid profile, though GI tolerability varies.
Berberine reduced HbA1c, fasting glucose, and lipid markers comparably to metformin (500 mg 3×/day). Both were similarly effective.
Berberine improved insulin resistance, androgen levels, and menstrual regularity in PCOS comparably to metformin, with better GI tolerability in some patients.
Berberine significantly reduced total cholesterol (-24 mg/dL), LDL (-25 mg/dL), and triglycerides (-44 mg/dL) vs placebo, effects comparable to mild statin doses.
We prioritize randomised controlled trials and meta-analyses over single observational studies. Animal and in-vitro data are listed as "mechanistic", they suggest direction, not human effect size.
We don't cherry-pick favourable studies, omit conflicting evidence, or cite industry-funded trials without flagging the conflict of interest where known.
The research is one thing, what to take, at what dose, paired with what, is another. We compose stacks that turn the evidence into a daily routine.
Studies referenced are real published research. Summaries are paraphrased for accessibility, for exact methods and full text, click through to PubMed. Educational use only, not medical advice. Consult a qualified clinician before starting any new supplement.